ArticleFrontiers in medicine2026

Nirmatrelvir/ritonavir reduced mortality in severe or critical COVID-19 patients: a multicenter retrospective cohort study.

Heng Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.